Newly Diagnosed Localized Cerebral Ependymoma in a Child Under 12 Months
This protocol addresses the first-line management of infants younger than 12 months of age who present with newly diagnosed, localized intracranial WHO grade II or III ependymoma, confirmed without CSF or spinal dissemination.
Clinical Scenario
Age under 12 months is the central defining factor in this population. Children in this youngest age group require a distinct management approach: chemotherapy alone is recommended in children aged less than 12 months, differentiating their care pathway from that of older children.
Treatment Approach (Overview)
Management begins with a surgical step directed at establishing a histological diagnosis, with the extent of resection representing a key determinant of subsequent care. The complete therapeutic sequence — including further modalities specific to this age group — is detailed in the structured protocol.
Full regimen, sequencing, and age-specific considerations available via the protocol below →
References
- Chemotherapy alone is an option in children less than 18 months old, while it is recommended in children aged less than 12 months.
- Resection is recommended to obtain a histological diagnosis and should be a gross total resection whenever feasible.
- Surgery and radiotherapy are the mainstay of treatment for ependymomas in children.
DOI: 10.1093/neuonc/nox166
View source ↗